Sumanta Garai

745 total citations
31 papers, 563 citations indexed

About

Sumanta Garai is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Sumanta Garai has authored 31 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 13 papers in Pharmacology. Recurrent topics in Sumanta Garai's work include Neuroscience and Neuropharmacology Research (13 papers), Cannabis and Cannabinoid Research (12 papers) and Receptor Mechanisms and Signaling (11 papers). Sumanta Garai is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Cannabis and Cannabinoid Research (12 papers) and Receptor Mechanisms and Signaling (11 papers). Sumanta Garai collaborates with scholars based in United States, Canada and India. Sumanta Garai's co-authors include Ganesh A. Thakur, Abhijit Kulkarni, Subhash P. Chavan, Roger L. Papke, Ganesh A. Thakur, Clare Stokes, Jiayi Pan, Lívia P. Mendes, Nina Filipczak and Vladimir P. Torchilin and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and Journal of Medicinal Chemistry.

In The Last Decade

Sumanta Garai

31 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sumanta Garai United States	14	303	203	190	114	47	31	563
Robert M. Burk United States	15	245 0.8×	328 1.6×	88 0.5×	275 2.4×	38 0.8×	31	883
Guisen Zhang China	18	534 1.8×	95 0.5×	239 1.3×	338 3.0×	12 0.3×	73	1.0k
N. Volz Germany	8	137 0.5×	124 0.6×	84 0.4×	217 1.9×	14 0.3×	16	426
Antonio Navarro Spain	19	447 1.5×	70 0.3×	130 0.7×	494 4.3×	14 0.3×	38	968
Stefania Dragoni Italy	12	131 0.4×	87 0.4×	97 0.5×	66 0.6×	24 0.5×	17	396
Patrizia Minetti Italy	14	242 0.8×	126 0.6×	96 0.5×	197 1.7×	7 0.1×	28	518
Stefania Baraldi Italy	18	398 1.3×	116 0.6×	103 0.5×	370 3.2×	8 0.2×	29	906
Geoffray Labar Belgium	15	305 1.0×	571 2.8×	126 0.7×	214 1.9×	4 0.1×	20	924
Yanhong Xing China	14	252 0.8×	30 0.1×	92 0.5×	149 1.3×	8 0.2×	28	580
Riku Niemi Finland	13	173 0.6×	371 1.8×	174 0.9×	116 1.0×	9 0.2×	23	702

Countries citing papers authored by Sumanta Garai

Since Specialization

Citations

This map shows the geographic impact of Sumanta Garai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumanta Garai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumanta Garai more than expected).

Fields of papers citing papers by Sumanta Garai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumanta Garai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumanta Garai. The network helps show where Sumanta Garai may publish in the future.

Co-authorship network of co-authors of Sumanta Garai

This figure shows the co-authorship network connecting the top 25 collaborators of Sumanta Garai. A scholar is included among the top collaborators of Sumanta Garai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumanta Garai. Sumanta Garai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oliva, Idaira, Claudia Rangel‐Barajas, Yvonne Y. Lai, et al.. (2022). Inhibition of PSD95‐nNOS protein–protein interactions decreases morphine reward and relapse vulnerability in rats. Addiction Biology. 27(5). e13220–e13220. 12 indexed citations

Greba, Quentin, Sumanta Garai, Orhan Yılmaz, et al.. (2022). The type 1 cannabinoid receptor positive allosteric modulators GAT591 and GAT593 reduce spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg. IBRO Neuroscience Reports. 12. 121–130. 9 indexed citations

Garai, Sumanta, Ayat Zagzoog, Dow P. Hurst, et al.. (2022). Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593. Frontiers in Pharmacology. 13. 919605–919605. 6 indexed citations

Hamouda, Ayman K., Yasmin Alkhlaif, Asti Jackson, et al.. (2021). Potentiation of (α4)2(β2)3, but not (α4)3(β2)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms. Neuropharmacology. 190. 108568–108568. 10 indexed citations

Greba, Quentin, Sumanta Garai, Eileen M. Denovan‐Wright, et al.. (2021). Antipsychotic potential of the type 1 cannabinoid receptor positive allosteric modulator GAT211: preclinical in vitro and in vivo studies. Psychopharmacology. 238(4). 1087–1098. 9 indexed citations

Greba, Quentin, Mariam Alaverdashvili, Wendie N. Marks, et al.. (2021). Positive allosteric modulation of type 1 cannabinoid receptors reduces spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg. Neuropharmacology. 190. 108553–108553. 25 indexed citations

Anderson, Lyndsey L., Peter T. Doohan, Nicole A. Hawkins, et al.. (2021). The endocannabinoid system impacts seizures in a mouse model of Dravet syndrome. Neuropharmacology. 205. 108897–108897. 13 indexed citations

Garai, Sumanta, Robert B. Laprairie, David R. Janero, et al.. (2021). Design, synthesis, and pharmacological profiling of cannabinoid 1 receptor allosteric modulators: Preclinical efficacy of C2-group GAT211 congeners for reducing intraocular pressure. Bioorganic & Medicinal Chemistry. 50. 116421–116421. 10 indexed citations

Slivicki, Richard A., Sonali S. Mali, Sumanta Garai, et al.. (2020). Positive Allosteric Modulation of CB1 Cannabinoid Receptor Signaling Enhances Morphine Antinociception and Attenuates Morphine Tolerance Without Enhancing Morphine- Induced Dependence or Reward. Frontiers in Molecular Neuroscience. 13. 54–54. 50 indexed citations

10.

Greba, Quentin, et al.. (2020). Effects of the cannabinoid receptor 1 positive allosteric modulator GAT211 and acute MK-801 on visual attention and impulsivity in rats assessed using the five-choice serial reaction time task. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 109. 110235–110235. 8 indexed citations

11.

Xu, Yu, Andrei I. Molosh, Leigh D. Plant, et al.. (2020). The small molecule GAT1508 activates brain-specific GIRK1/2 channel heteromers and facilitates conditioned fear extinction in rodents. Journal of Biological Chemistry. 295(11). 3614–3634. 23 indexed citations

12.

Papke, Roger L., Sumanta Garai, Clare Stokes, et al.. (2020). Differing Activity Profiles of the Stereoisomers of 2,3,5,6TMP-TQS, a Putative Silent Allosteric Modulator of α7 nAChR. Molecular Pharmacology. 98(4). 292–302. 8 indexed citations

13.

Miller, Douglas R., Habibeh Khoshbouei, Sumanta Garai, et al.. (2020). Allosterically Potentiated α7 Nicotinic Acetylcholine Receptors: Reduced Calcium Permeability and Current-Independent Control of Intracellular Calcium. Molecular Pharmacology. 98(6). 695–709. 12 indexed citations

14.

Pan, Jiayi, Lívia P. Mendes, Nina Filipczak, et al.. (2019). Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance. European Journal of Pharmaceutics and Biopharmaceutics. 136. 18–28. 82 indexed citations

15.

Gulsevin, Alican, Roger L. Papke, Clare Stokes, et al.. (2019). Allosteric Agonism of α7 Nicotinic Acetylcholine Receptors: Receptor Modulation Outside the Orthosteric Site. Molecular Pharmacology. 95(6). 606–614. 26 indexed citations

16.

Stokes, Clare, Sumanta Garai, Abhijit Kulkarni, et al.. (2019). Heteromeric Neuronal Nicotinic Acetylcholine Receptors with Mutant β Subunits Acquire Sensitivity to α7-Selective Positive Allosteric Modulators. Journal of Pharmacology and Experimental Therapeutics. 370(2). 252–268. 10 indexed citations

17.

Hurst, Dow P., et al.. (2019). Identification of CB1 Receptor Allosteric Sites Using Force-Biased MMC Simulated Annealing and Validation by Structure–Activity Relationship Studies. ACS Medicinal Chemistry Letters. 10(8). 1216–1221. 28 indexed citations

18.

Xu, Yu, Takeharu Kawano, Lia Baki, et al.. (2018). Hydrogen sulfide inhibits Kir2 and Kir3 channels by decreasing sensitivity to the phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2). Journal of Biological Chemistry. 293(10). 3546–3561. 16 indexed citations

19.

Quadri, Marta, Sumanta Garai, Ganesh A. Thakur, et al.. (2018). Macroscopic and Microscopic Activation of α7 Nicotinic Acetylcholine Receptors by the Structurally Unrelated Allosteric Agonist-Positive Allosteric Modulators (ago-PAMs) B-973B and GAT107. Molecular Pharmacology. 95(1). 43–61. 22 indexed citations

20.

Chavan, Subhash P., Sumanta Garai, & Uttam R. Kalkote. (2012). A highly diastereoselective total synthesis of (±)-heritonin and (±)-heritol. Tetrahedron. 68(40). 8509–8514. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact